magnesium hydroxide antacid
Selected indexed studies
- Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects. (Antimicrob Agents Chemother, 2023) [PMID:36943038]
- Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide. (Am J Hosp Pharm, 1982) [PMID:7148862]
- Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses. (J Am Vet Med Assoc, 1996) [PMID:8641951]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects. (2023) pubmed
- Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide. (1982) pubmed
- Effect of aluminum hydroxide/magnesium hydroxide antacid and bismuth subsalicylate on gastric pH in horses. (1996) pubmed
- Effects of magnesium-aluminum hydroxide antacid on absorption of rufloxacin. (1993) pubmed
- Magnesium aluminum hydroxide gel in the antacid therapy of peptic ulcer. (1954) pubmed
- Antacid therapy--changes in mineral metabolism. (1982) pubmed
- Antacids and hormones. (1982) pubmed
- The effect of a combination antacid preparation containing aluminium hydroxide and magnesium hydroxide on rosuvastatin pharmacokinetics. (2008) pubmed
- Magnesium hydroxide/aluminium hydroxide-containing antacid does not affect the pharmacokinetics of the targeted phosphodiesterase 4 inhibitor roflumilast. (2007) pubmed
- Effect of an orally administered antacid agent containing aluminum hydroxide and magnesium hydroxide on abomasal luminal pH in clinically normal milk-fed calves. (2002) pubmed